Having only just completed an expansion of its clinical supply facility in Illinois, PCI Pharma Services will now expand its solid dose facility in Wales in the U.K.
Philadelphia-based PCI says it is doubling the large-scale granulation and fluid bed drying capacity at the Wales facility. It also is adding space for new potent handling capabilities as well as areas for additional analytical and small-scale processing that will permit it to do early-stage, non-GMP processing and formulation.
It expects the expansion to be complete in 2021. It did not disclose its investment.
The work in the U.K. follows completion of a 30,000-square-foot expansion of PCI's facility in Rockford, Illinois, where it added primary and secondary packaging as well as labeling for clinical supplies. It also included a temperature-controlled suite
Earlier in the year, the company said it would add a 75,000-square-foot clinical supply facility near Dublin that can handle both primary and secondary packaging, storage, logistics and distribution.